A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine?

Maughan TS, Meade AM, Adams RA, Richman SD, Butler R, Fisher D, Wilson RH, Jasani B, Taylor GR, Williams GT, Sampson JR, Seymour MT, Nichols LL, Kenny SL, Nelson A, Sampson CM, Hodgkinson E, Bridgewater JA, Furniss DL, Roy R, Pope MJ, Pope JK, Parmar M, Quirke P, Kaplan R

Open source

DOI: 10.1038/bjc.2014.182
Published: 2014 Apr 29
Container: British journal of cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/bjc.2014.182,
  title = {A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine?},
  author = {Maughan TS and Meade AM and Adams RA and Richman SD and Butler R and Fisher D and Wilson RH and Jasani B and Taylor GR and Williams GT and Sampson JR and Seymour MT and Nichols LL and Kenny SL and Nelson A and Sampson CM and Hodgkinson E and Bridgewater JA and Furniss DL and Roy R and Pope MJ and Pope JK and Parmar M and Quirke P and Kaplan R},
  year = {2014},
  journal = {British journal of cancer},
  doi = {10.1038/bjc.2014.182},
  url = {https://doi.org/10.1038/bjc.2014.182}
}

RIS

TY  - JOUR
TI  - A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine?
AU  - Maughan TS
AU  - Meade AM
AU  - Adams RA
AU  - Richman SD
AU  - Butler R
AU  - Fisher D
AU  - Wilson RH
AU  - Jasani B
AU  - Taylor GR
AU  - Williams GT
AU  - Sampson JR
AU  - Seymour MT
AU  - Nichols LL
AU  - Kenny SL
AU  - Nelson A
AU  - Sampson CM
AU  - Hodgkinson E
AU  - Bridgewater JA
AU  - Furniss DL
AU  - Roy R
AU  - Pope MJ
AU  - Pope JK
AU  - Parmar M
AU  - Quirke P
AU  - Kaplan R
PY  - 2014
JO  - British journal of cancer
DO  - 10.1038/bjc.2014.182
UR  - https://doi.org/10.1038/bjc.2014.182
ER  -

APA

TS, M., AM, M., RA, A., SD, R., R, B., D, F., RH, W., B, J., GR, T., GT, W., JR, S., MT, S., LL, N., SL, K., A, N., CM, S., E, H., JA, B., DL, F., R, R., MJ, P., JK, P., M, P., P, Q., & R, K. (2014). A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine?. British journal of cancer. https://doi.org/10.1038/bjc.2014.182

Source records

pubmed · retrieved 2026-09-26T13:23:18.353Z